文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

内在能力及其变化可预测早期心血管-肾脏-代谢综合征的心血管疾病风险:一项全国性队列研究

Intrinsic capacity and its change predict cardiovascular disease risk in early cardiovascular-kidney-metabolic syndrome: a nationwide cohort study.

作者信息

Song Fei, Hu Meng-Jin, Xia Jinggang, Yin Chunlin

机构信息

Department of Cardiology, Xuanwu Hospital Capital Medical University, Beijing, China.

Department of Cardiology, Xuanwu Hospital Capital Medical University, Beijing, China

出版信息

Open Heart. 2025 Aug 18;12(2):e003395. doi: 10.1136/openhrt-2025-003395.


DOI:10.1136/openhrt-2025-003395
PMID:40829891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12366564/
Abstract

BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome plays a critical role in the pathogenesis of cardiovascular diseases (CVD). Growing evidence has established that impaired intrinsic capacity (IC) served as a robust predictor of adverse health outcomes. However, its specific association with incident CVD in CKM syndrome populations has not been established. METHODS: The China Health and Retirement Longitudinal Study is a nationally representative cohort study in China. First, the relationship between baseline IC and the incidence of CVD was analysed using Cox regression models. Subsequently, subgroup and interaction analyses were conducted among different groups. To investigate the potential non-linear relationship between baseline IC and CVD risk, restricted cubic spline (RCS) regression of HR was employed. Furthermore, IC trajectories over time were analysed using group-based trajectory modelling. The associations of the trajectory memberships with CVD risk were analysed using logistic regression models. RESULTS: Among 5346 participants included, of whom 2712 (50.7%) were men and 2634 (49.3%) were women, with a mean age of 57.3 (9.02) years. The results of the fully adjusted Cox regression analyses indicated that there was an 8% decrease in risk for every 1-score rise in IC (HR=0.92, 95% CI: 0.87 to 0.98). The RCS regression analyses demonstrated a linear association between baseline IC and CVD risk in the CKM syndrome population. Subgroup and interaction analyses showed no interactions observed in any subgroups. Trajectory analysis identified three longitudinal patterns of IC with age: class 1, 'low level' (12%); class 2, 'medium level' (25%); class 3, 'high level' (63%). Logistic regression models indicated that both 'low level' and 'medium level' IC trajectories were independently associated with significantly higher CVD risk compared with the 'high level' reference group. CONCLUSIONS: This prospective cohort study demonstrated significant associations between both baseline IC and its longitudinal changes with incident CVD risk among individuals with CKM syndrome stages 0-3.

摘要

背景:心血管-肾脏-代谢(CKM)综合征在心血管疾病(CVD)的发病机制中起关键作用。越来越多的证据表明,内在能力(IC)受损是不良健康结局的有力预测指标。然而,其与CKM综合征人群中CVD发病的具体关联尚未明确。 方法:中国健康与养老追踪调查是一项具有全国代表性的队列研究。首先,使用Cox回归模型分析基线IC与CVD发病率之间的关系。随后,在不同组间进行亚组分析和交互作用分析。为了研究基线IC与CVD风险之间潜在的非线性关系,采用了HR的受限立方样条(RCS)回归。此外,使用基于组的轨迹模型分析IC随时间的轨迹。使用逻辑回归模型分析轨迹类别与CVD风险的关联。 结果:纳入的5346名参与者中,男性2712名(50.7%),女性2634名(49.3%),平均年龄57.3(9.02)岁。完全调整后的Cox回归分析结果表明,IC每升高1分,风险降低8%(HR=0.92,95%CI:0.87至0.98)。RCS回归分析表明,CKM综合征人群中基线IC与CVD风险呈线性关联。亚组分析和交互作用分析显示,在任何亚组中均未观察到交互作用。轨迹分析确定了IC随年龄变化的三种纵向模式:第1类,“低水平”(12%);第2类,“中等水平”(25%);第3类,“高水平”(63%)。逻辑回归模型表明,与“高水平”参考组相比,“低水平”和“中等水平”的IC轨迹均与显著更高的CVD风险独立相关。 结论:这项前瞻性队列研究表明,在0-3期CKM综合征个体中,基线IC及其纵向变化与CVD发病风险均存在显著关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/73ad9fa2db27/openhrt-12-2-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/f7c50caea5e0/openhrt-12-2-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/4d28233ab1b4/openhrt-12-2-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/74e2226f4362/openhrt-12-2-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/73ad9fa2db27/openhrt-12-2-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/f7c50caea5e0/openhrt-12-2-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/4d28233ab1b4/openhrt-12-2-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/74e2226f4362/openhrt-12-2-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca5d/12366564/73ad9fa2db27/openhrt-12-2-g004.jpg

相似文献

[1]
Intrinsic capacity and its change predict cardiovascular disease risk in early cardiovascular-kidney-metabolic syndrome: a nationwide cohort study.

Open Heart. 2025-8-18

[2]
C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-7-22

[3]
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank.

Cardiovasc Diabetol. 2025-7-10

[4]
Association between Chinese visceral adiposity index and cardiovascular events risk in individuals with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide cohort study.

Int Urol Nephrol. 2025-2-12

[5]
Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study.

Cardiovasc Diabetol. 2025-7-26

[6]
Association of Atherogenic Index of Plasma With Stroke Risk in a Population With Cardiovascular-Kidney-Metabolic Syndrome Stages 0 to 3: The First Evidence From the China Health and Retirement Longitudinal Study.

J Am Heart Assoc. 2025-7-15

[7]
Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study.

PLoS Med. 2025-6-26

[8]
Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China Health and Retirement Longitudinal Study.

Eur J Prev Cardiol. 2025-4-24

[9]
Association Between the Serum Creatinine to Cystatin C Ratio and Cardiovascular Disease in Middle-Aged and Older Adults in China: A Nationwide Cohort Study.

J Am Heart Assoc. 2025-5-6

[10]
Cardiovascular-kidney-metabolic syndrome and incidence of dementia among older adults.

J Prev Alzheimers Dis. 2025-5

本文引用的文献

[1]
Association between multimorbidity and intrinsic capacity among older Chinese adults: evidence from the CHARLS 2011-2015.

Eur Geriatr Med. 2025-5-26

[2]
Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2025-3-29

[3]
The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies.

Cardiovasc Diabetol. 2025-3-24

[4]
U-shaped relationship of estimated glucose disposal rate with cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stages 0-3: a population-based prospective study.

Diabetol Metab Syndr. 2025-3-11

[5]
Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality.

Atherosclerosis. 2024-10

[6]
Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study.

Cardiovasc Diabetol. 2024-8-7

[7]
Association of intrinsic capacity with functional decline and mortality in older adults: a systematic review and meta-analysis of longitudinal studies.

Lancet Healthy Longev. 2024-7

[8]
Stress and cardiovascular disease: an update.

Nat Rev Cardiol. 2024-9

[9]
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.

J Am Coll Cardiol. 2024-5-7

[10]
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

Kidney Int. 2024-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索